US Stock MarketDetailed Quotes

SLN Silence Therapeutics

Watchlist

7.670
+0.210+2.82%

Close Nov 27 16:00 ET

7.610
-0.060-0.78%

Post 20:01 ET

362.14MMarket Cap-4501P/E (TTM)

Silence Therapeutics Stock Forum

Mcsnacks H Tupack

Nov 22 02:52

Top 2 Long Term stocks(3 months)

$Silence Therapeutics (SLN.US)$ Stock rated a buy and with the lowest PT being $31. Had the same dip last year so it will be around February 21 when it reaches its PT.
$Rezolve AI (RZLV.US)$ Alot of short shares sold this month and in September. Reversal should be starting now that it has reached $1.63. First climb will be to 4.70 with that PT being at the end of December. February's PT will be 12.00. Partnerships with Microsoft and Google will push it until they re...

Johnny Mnemonic

Nov 20 14:53

still severely oversold

Johnny Mnemonic

Nov 20 13:29

shorts gonna get burned if they don't get out, there's this much outflow and still pushing, be careful

Stock_Drift

Nov 18 14:13

$Silence Therapeutics (SLN.US)$

Moomoo AI

Feb 3 06:08

Despite strong growth, Silence Therapeutics' high P/S ratio and weak revenue outlook suggest a risk of share price decline. Analysts lack confidence in a business turnaround, indicating potential risk for shareholders and potential investors.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 26% But Growth Is Lacking

Moomoo AI

Nov 27, 2023 04:17

Analysts' confidence appears low for Silence Therapeutics' business turnaround. The high P/S ratio and expected revenue decline suggest unsustainable current price levels which may erode current sentiment towards the stock.

Optimistic Investors Push Silence Therapeutics Plc (NASDAQ:SLN) Shares Up 65% But Growth Is Lacking

Trytosaveabit

Nov 1, 2023 06:13

News

$Silence Therapeutics (SLN.US)$ Silence Therapeutics Reports Topline Results From Phase 1 Multiple Dose Study Of Zerlasiran; Lp(a) Levels Remained Around 90% Lower Than Baseline At Study Endpoint